Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1991
03/20/1991EP0417588A2 Process for the preparation of a complexed drug
03/20/1991EP0417496A2 Transdermal nitroglycerin patch with penetration enhancers
03/20/1991EP0417245A1 Topical analgesic composition
03/20/1991EP0417209A1 Compositions and methods for administering therapeutically active compounds
03/20/1991EP0417188A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles
03/20/1991EP0417154A1 Method upon a temperature increase of counteracting a viscosity decrease or providing a viscosity increase in a water-base system containing a polymer as viscosity agent.
03/20/1991EP0408558A4 Hydrophilic polyurethanes prepared from mixed oxyalkylene glycols
03/20/1991EP0406307A4 Water soluble ibuprofen compositions and methods of making them
03/19/1991US5001225 Monoclonal antibodies to a pan-malarial antigen
03/19/1991US5001161 Pharmaceutical composition comprising metroprolol succinate
03/19/1991US5001139 Enchancers for the transdermal flux of nivadipine
03/19/1991US5000960 Using bifunctional agent to form disulfide bond
03/19/1991US5000959 Liposome composition and production thereof
03/19/1991US5000955 Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
03/19/1991US5000947 Shaped articles containing liquefiable powders for delivery of cosmetic and other personal care agents
03/19/1991CA2025118A1 Preservative for ophthalmic solutions
03/19/1991CA1281652C Readily absorbable pharmaceutical composition
03/19/1991CA1281651C Water soluble polyvinyl lactam-drug complexes
03/19/1991CA1281650C Aqueous preparation containing cyclodextrin
03/19/1991CA1281647C Compositions and methods for the treatment of bleeding disorders
03/15/1991WO1991004059A2 Method and useful apparatus for preparing pharmaceutical compositions
03/15/1991WO1991004050A1 Therapeutic compositions; methods for treatment of hiv infections
03/15/1991CA2067158A1 Method and useful apparatus for preparing pharmaceutical compositions
03/15/1991CA2065029A1 Therapeutic compositions; methods for treatment of hiv infections
03/13/1991EP0416842A1 Solid matrix system for transdermal drug delivery
03/13/1991EP0416804A1 External preparation containing amusulosin
03/13/1991EP0416773A2 Vitamin B12 composition
03/13/1991EP0416739A1 Pharmaceutical compositions containing penciclovir
03/13/1991EP0416575A2 Drug delivery compositions based on biological materials and methods for preparing such compositions
03/13/1991EP0416250A2 N-acylurea and O-acylisourea derivatives of hyaluronic acid
03/13/1991EP0416232A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
03/13/1991EP0416137A1 Method for reducing skin irritation associated with drug/penetration enhancer compositions
03/13/1991EP0416034A1 Penetration enhancers for transdermal delivery of systemic agent
03/13/1991EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits
03/13/1991EP0415922A1 Integrity protected gelatin
03/13/1991CN1049865A Plasminogen activator complex of pure prourokinase covalently bound by disulfide bridge to human serum albumin
03/12/1991WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION
03/12/1991US4999435 Cationic Surfactants, Drugs, Immunoassay
03/12/1991US4999379 Novel pharmaceutical compositions for topical application with systemic action
03/12/1991US4999375 Psoralen reagent compositions for extracorporeal treatment of blood
03/12/1991US4999189 Sustained release oral suspensions
03/12/1991US4999188 Methods for embolization of blood vessels
03/12/1991US4999058 Low calorie sweetener
03/12/1991CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation
03/12/1991CA2024887A1 Pharmaceutical preparations
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/09/1991WO1991003219A1 Solid matrix system for transdermal drug delivery
03/08/1991WO1991003259A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
03/08/1991CA2066244A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
03/07/1991WO1991002763A1 Polymeric materials
03/07/1991WO1991002543A1 Stabilized vaccine compositions
03/07/1991WO1991002541A1 Detection and treatment of infections with immunoconjugates
03/07/1991WO1991002518A1 Pharmaceutical compositions and a device for administering the same
03/07/1991WO1990014844A3 Sugars as cleavable linkers for the delivery and release of agents in native form
03/07/1991DE4019062A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon
03/07/1991CA2065023A1 Stabilized vaccine compositions
03/07/1991CA2064882A1 Pharmaceutical compositions and a device for administering the same
03/06/1991EP0415567A2 Composition and method for stabilising organic compounds
03/06/1991EP0415430A1 Stable solutions of mitomycin C
03/06/1991EP0415263A2 Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives
03/06/1991EP0414730A1 Luminide and macroluminide class of pharmaceuticals
03/06/1991CA2024587A1 Drug delivery compositions based on biological cells or components thereof and methods
03/05/1991US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy
03/05/1991US4997819 Pullulan, amylopectin, or dextrin
03/05/1991US4997667 Pyridinyl compounds of N-carbamoyl-N-thiocarbamoyl- or N-amidino-glycine or beta-alanine useful as sweetening agents
03/05/1991US4997651 Pharmaceutical formulations
03/05/1991US4997643 Polymeric salt delivery systems
03/05/1991CA2024438A1 External preparation containing amusulosin
03/05/1991CA1280977C Polyprenyl alcohol-containing injections
03/05/1991CA1280976C Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thusobtained
03/05/1991CA1280974C Transdermal delivery system
03/05/1991CA1280973C Analgesic stick compositions
03/02/1991CA2023995A1 Stable solutions of mitomycin c
03/02/1991CA2021548A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content
03/01/1991WO1991003548A1 Superoxide dismutase-catalase conjugates
03/01/1991WO1991003494A1 Cationized carriers for immunogen production
03/01/1991WO1991003227A1 Topical antiinflammatory compositions with minimal systemic absorption
03/01/1991CA2067124A1 Cationized carriers for immunogen production
03/01/1991CA2065430A1 Superoxide dismutase - catalase conjugates
03/01/1991CA2064189A1 Topical antiinflammatory compositions with minimal systemic absorption
03/01/1991CA2024171A1 Low-irritative nasal preparation
03/01/1991CA2024130A1 Bioerodible polymers useful for the controlled release of therapeutic agents
02/1991
02/27/1991EP0414373A2 Stable solution of hyaluronate in a balanced salt medium
02/27/1991EP0414263A2 Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids.
02/27/1991EP0414233A2 Medical electrical lead with polymeric monolithic controlled realease device
02/27/1991EP0414080A2 Non-parenteral pharmaceutical compositions for insulin
02/27/1991EP0413957A2 Pulmonary surfactant protein fragments
02/27/1991EP0413828A1 Solid preparation of active vitamin d3 having improved stability
02/27/1991EP0413709A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
02/27/1991CN1049455A Pharmaceutical dosage form improving bioavailability
02/27/1991CN1049451A Antibiotic composition
02/26/1991US4996233 Method of reducing porphyrin toxicity using fatty acids
02/26/1991US4996199 Penetration enhancers for transdermal delivery of systemic agents
02/26/1991US4996197 Pharmaceutical and/or cosmetic composition for local use containing Rhamsan gum
02/26/1991US4996196 Dehydrated product containing crystalline b-maltose hydrate
02/26/1991US4996193 Combined topical and systemic method of administration of cyclosporine
02/26/1991US4996074 Tailored beta-prime stable triglyceride hardstock
02/26/1991US4996058 Covered retard forms
02/26/1991US4996047 Sustained release drug-resin complexes
02/26/1991US4995897 Method of making inorganically crosslinked layered compounds
1 ... 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 ... 1712